Biofrontera AG (B8F.DE) XETRA
6.80
+6.48(+2000.00%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 589.58M |
| Enterprise Value | 587.64M |
| P/E Ratio | -1.09 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0.31 |
| Price/Book Ratio | 1.98 |
| Enterprise/Revenue | 0.34 |
| Enterprise/EBITDA | -1.76 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | March 31, 2024 |
Profitability
| Profit Margin | -0.26 |
| Operating Margin | -0.21 |
Management Effectiveness
| Return On Assets | -0.45 |
| Return On Equity | -4.77 |
Income Statement
| Revenue | 32.25M |
| Revenue/Share | 3.7 |
| Gross Profit | 25.37M |
| EBITDA | 5.57M |
| Net Income | -369,000 |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 3.29M |
| Total Cash/Share | 0.54 |
| Total Debt | 1.04M |
| Total Debt/Equity | 1.27 |
| Current Ratio | 1.2 |
| Book Value Per Share | 0.52 |
Price History
| 52-Week Change | 680.28 |
| 52-Week High | 22.58 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 6.53 |
| Moving Average 200 Days | 9.19 |
Statistics
| Average Volume | 605 |
| Shares Outstanding | 3.04M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:21 |
| Last Split Date | May 14, 2024 |
